Total Payments
$289,614
2024 Payments
$20,461
Companies
44
Transactions
988
Medicare Patients
927
Medicare Billing
$310,927
Payment Breakdown by Category
Other$225,440 (77.8%)
Food & Beverage$26,179 (9.0%)
Travel$25,088 (8.7%)
Consulting$10,032 (3.5%)
Education$2,875 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $219,440 | 142 | 75.8% |
| Food and Beverage | $26,179 | 645 | 9.0% |
| Travel and Lodging | $25,088 | 113 | 8.7% |
| Consulting Fee | $10,032 | 4 | 3.5% |
| Honoraria | $6,000 | 3 | 2.1% |
| Education | $2,875 | 81 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $69,575 | 155 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $34,933 | 67 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $33,104 | 49 | $0 (2024) |
| Relypsa, Inc. | $33,064 | 85 | $0 (2020) |
| Travere Therapeutics, Inc. | $32,643 | 67 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $26,572 | 106 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $19,994 | 91 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $17,827 | 44 | $0 (2018) |
| Vifor Pharma, Inc. | $8,188 | 35 | $0 (2024) |
| Amgen Inc. | $3,904 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,461 | 70 | Travere Therapeutics, Inc. ($16,727) |
| 2023 | $22,300 | 75 | Travere Therapeutics, Inc. ($15,897) |
| 2022 | $51,651 | 112 | Bayer HealthCare Pharmaceuticals Inc. ($20,980) |
| 2021 | $53,142 | 138 | AstraZeneca Pharmaceuticals LP ($22,855) |
| 2020 | $14,365 | 78 | AstraZeneca Pharmaceuticals LP ($5,365) |
| 2019 | $39,788 | 144 | AKEBIA THERAPEUTICS INC ($12,471) |
| 2018 | $43,440 | 167 | Keryx Biopharmaceuticals, Inc. ($17,721) |
| 2017 | $44,467 | 204 | Alexion Pharmaceuticals, Inc. ($14,015) |
All Payment Transactions
988 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/12/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Nephrology | ||||||
| 11/07/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $88.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEPHROLOGY | ||||||
| 10/14/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,600.00 | General |
| 10/14/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $169.82 | General |
| 10/14/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $33.53 | General |
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $363.96 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $339.29 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $85.00 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 09/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.80 | General |
| 09/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $122.25 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardio-renal | ||||||
| 08/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.19 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 88 | 122 | $61,579 | $14,997 |
| 2022 | 4 | 173 | 303 | $85,435 | $45,595 |
| 2021 | 4 | 285 | 635 | $202,315 | $117,184 |
| 2020 | 9 | 381 | 882 | $288,695 | $133,151 |
Total Patients
927
Total Services
1,942
Medicare Billing
$310,927
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 60 | $24,000 | $5,788 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 39 | $21,801 | $5,473 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $15,778 | $3,736 | 23.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2022 | 19 | 79 | $39,500 | $22,733 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 162 | $30,185 | $13,828 | 45.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2022 | 15 | 29 | $11,600 | $7,037 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 33 | $4,150 | $1,996 | 48.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2021 | 39 | 239 | $119,500 | $70,860 | 59.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 284 | $52,540 | $28,871 | 55.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2021 | 36 | 59 | $23,600 | $14,492 | 61.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 53 | $6,675 | $2,960 | 44.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2020 | 44 | 344 | $172,000 | $82,396 | 47.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 163 | 312 | $57,720 | $24,742 | 42.9% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2020 | 31 | 63 | $25,200 | $12,735 | 50.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 79 | $10,000 | $4,377 | 43.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $4,675 | $2,909 | 62.2% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Facility | 2020 | 11 | 15 | $4,500 | $2,356 | 52.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 17 | $3,400 | $1,493 | 43.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 18 | $2,700 | $1,080 | 40.0% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 13 | 17 | $8,500 | $1,064 | 12.5% |
About Dr. Richard Cottiero, MD
Dr. Richard Cottiero, MD is a Internal Medicine healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295733988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Cottiero, MD has received a total of $289,614 in payments from pharmaceutical and medical device companies, with $20,461 received in 2024. These payments were reported across 988 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($219,440).
As a Medicare-enrolled provider, Cottiero has provided services to 927 Medicare beneficiaries, totaling 1,942 services with total Medicare billing of $310,927. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Nephrology
- Location Las Vegas, NV
- Active Since 07/07/2005
- Last Updated 01/26/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1295733988
Products in Payments
- FARXIGA (Drug) $49,155
- Veltassa (Drug) $41,015
- Auryxia (Drug) $38,209
- Kerendia (Drug) $33,104
- LOKELMA (Drug) $19,864
- JYNARQUE (Drug) $18,110
- AURYXIA (Drug) $14,508
- SOLIRIS (Drug) $14,264
- KRYSTEXXA (Biological) $3,409
- ULTOMIRIS (Biological) $2,734
- TOLVAPTAN (Drug) $1,892
- SAMSCA (Drug) $1,419
- JARDIANCE (Drug) $764.10
- ACTHAR (Biological) $756.60
- XARELTO (Drug) $582.78
- Velphoro (Drug) $499.63
- LUPKYNIS (Drug) $443.06
- Parsabiv (Biological) $420.92
- Parsabiv (Drug) $389.99
- BENLYSTA (Biological) $354.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Las Vegas
Fadi Braiteh, M.d, M.D
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Samer Nakhle, Md, MD
Internal Medicine — Payments: $911,236
Internal Medicine $911,236
Maxine Ingham, Md, MD
Internal Medicine — Payments: $602,393
Internal Medicine $602,393
Dr. Michael Jacobs, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $237,373
Internal Medicine $237,373
Dr. Kevin Dunsmoor, Do, DO
Internal Medicine — Payments: $197,836
Internal Medicine $197,836
Dr. Filippo Cremonini, Md, MD
Internal Medicine — Payments: $169,922
Internal Medicine $169,922